Dendrobium traditional Chinese medicine composition, preparation method and application thereof

Abstract

The invention discloses a dendrobium traditional Chinese medicine composition, a preparation method and application thereof. The dendrobium traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 1-2 parts of dendrobium, 1-3 parts of turtle shell and 1-2 parts of pseudo-ginseng. The preparation method comprises the following steps: respectively micro-pulverizing the raw materials to 10-60 thousand meshes, evenly mixing, and processing into an oral solid preparation. The dendrobium traditional Chinese medicine composition can be used for treating aplastic anemia, and has obvious effect. The traditional Chinese medicine composition has the effects of nourishing yin and suppressing hyperactive yang, tonifying the kidney, regenerating the marrow, promoting blood circulation and nourishing the blood, and is safe and effective. Compared with common pulverization, the preparation method disclosed by the invention can greatly enhance the absorption availability of rare medicinal herbs, and effectively reduce the dosage. Compared with a common decoction method, the preparation method disclosed by the invention can overcome the defects of high time and labor consumption and low extraction rate due to long-time decoction, effectively lower the production cost and enhance the drug effect.

Description

1. Technical field [0001] The present invention relates to a traditional Chinese medicine composition, its preparation method and its use, in particular to a dendrobium traditional Chinese medicine composition, its preparation method and its use. 2. Background technology [0002] Aplastic anemia (AA), referred to as aplastic anemia, is a serious hematopoietic system disease characterized by pancytopenia and bone marrow hematopoietic failure. In recent years, the annual incidence rate abroad is 2 / 100,000 people, and the domestic annual incidence rate is 7.4 / 100,000 people, of which acute aplastic anemia is 1.4 / 100,000 people. Increase, the incidence has a rising trend year by year. Severe aplastic anemia progresses rapidly and has a high mortality rate, with the mortality rate reaching over 90% within one year, which seriously threatens human health. The etiology of aplastic anemia is not yet fully understood, but most of them are related to known drugs, chemical substances...

AI Technical Summary

Problems solved by technology

Since the 1950s, TCM treatment of aplastic anemia has been roughly divided into three stages. Before the 1960s, it was mainly based on nourishing the heart and spleen or nourishing qi and blood; , almost all focus on invigorating the kidney, or at the same time nourishing qi and blood, or at the same time, or at the same time, or at the same time, or at the same time, or at the same time, or at the same time, or at the same time, or at the same time, or at the same time, or at the same time. There are many empirical prescriptions, but most of them are simple decoctions and self-made medicines. There are not many medicines standardized and developed according to the new drug standards. At present, there are mainly traditional Chinese medicines such as Compound Zaofan Pills and Xuebao Capsules on the market. , but the process is simple, the dosage form is backward, there are dozens of medicinal flavors, the active substance is not clear, the quality control technology content is low, the patient is inconvenient to take it, and the compliance is poor. It is difficult to guarantee the efficacy of the product, which affects clinical use.

Images